FDA Panel to Review Moderna’s Flu Vaccine for Older Adults
The U.S. Food and Drug Administration’s (FDA) independent vaccine advisory panel is set to review and vote on whether the benefits of Moderna’s influenza vaccine, mFlusiva, outweigh its potential risks in older adults. Moderna...
Apotex Health Targets Up to C$1.2 Billion in Toronto IPO
Canadian healthcare company Apotex Health announced on Monday that it plans to raise up to C$1.2 billion through an initial public offering (IPO) on the Toronto Stock Exchange (TSX), marking one of the largest...